PATENT CLAIM ANALYSIS

Application Number: 16029352
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-12
Patent Classification: ["424", "174100"]

Abstract:
The present invention relates to therapeutic combinations and methods for treating cancers using combination therapy.

Claim (Index 17):
The method of  claim 1 , wherein said cancer is selected from the group consisting of: breast cancer, colorectal cancer, diffuse large B-cell lymphoma, endometrial cancer, follicular lymphoma, gastric cancer, glioblastoma, head and neck cancer, hepatocellular cancer, lung cancer, melanoma, multiple myeloma, ovarian cancer, pancreatic cancer, prostate cancer, and renal cell carcinoma.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 95.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15110685', '15793820', '15110690', '15849436', '15849470']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7961274628044914
- 35 USC 102 Novelty (BERT): 0.5344002018303325
- Combined Prediction Score: 0.7699547367070756
- Mean Citation Score: 337.588756
- Max Citation Score: 377.97064
- Similarity Product: 309.8885440180874

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test